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Background: Many women with structural heart disease reach reproductive age and contemplate mother-
hood. Pregnancy induces and requires major hemodynamic changes. Pregnant women with structural
heart disease may have a reduced cardiac reserve. There are no longitudinal data on cardiovascular adapta-
tion throughout pregnancy in women with structural heart disease.
Methods: Thirty-ﬁve women with structural heart disease were included in a prospective observational trial.
Maternal hemodynamics were assessed before conception, during pregnancy and 6 months postpartum by
transthoracic echocardiography. Uteroplacental perfusion was analyzed by obstetric Dopplers. Longitudinal
evolution over time was analyzed as well as the long term inﬂuence of pregnancy on cardiac function.
Results: Cardiac output (CO), stroke volume (SV), left ventricular mass (LV mass) and E/E′ ratio signiﬁcantly
increased and ejection fraction (EF) and fractional shortening (FS) decreased during pregnancy. There was a
statistically signiﬁcant difference in EF, FS and E/E′ ratio before and after pregnancy.
Conclusions: The characteristic pattern of hemodynamic adaptation to pregnancy is attenuated in women
with structural heart disease. The pregnancy related volume load induces progression of diastolic dysfunc-
tion. Our data suggest a persistent reduction in systolic and diastolic cardiac functions after pregnancy in
women with structural heart disease.© 2012 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Normal pregnancy induces and requires a major cardiac adapta-
tion. An initial arterial vasodilatation, early in pregnancy, triggers a
rapid increase in blood volume, cardiac output and ventricular mass
[1,2]. Most of these changes are reversed 6 months after pregnancy
[3].
Advances inmedical and surgical care of patientswith structural heart
disease have led to improved survival and outcome, especially in women
with congenital and valvular heart disease. Many of these women reach
reproductive age and experience their quality of life to be sufﬁcient to
consider pregnancy and motherhood. However, they are at increased
risk for cardiac and obstetric complications [4–6]. The hemodynamic
changes can put a strain on their circulatory system and may induce car-
diac complications such as heart failure or arrhythmia. Alternatively, their
reduced cardiac reserve could prevent adequate adaptation, possiblynd Gynaecology, Erasmus MC,
r. Molewaterplein 60, 3015 GJ
x: +31 10 703 6815.
e).
Ltd. All rights reserved.leading to hypertensive disorders of pregnancy, fetal growth restriction
or adverse fetal outcome.
Timely counseling and specialized follow up by a dedicated team
of cardiologists, obstetricians and anesthesiologists, with knowledge
of the implications of structural heart defects as well as adaptive re-
quirements of pregnancy, are therefore advised [7,8].
While cardiac (mal)adaptation to pregnancy hasmostly been studied
in healthy women, women with hypertensive disorders or with growth
restricted fetuses, there is hardly any longitudinal data on women with
structural heart disease [9]. As such most information comes from ex-
trapolation of other patient groups [10–17].
Also, little is known on the degree of reversibility of hemodynamic
adaptation and its effects on cardiac function after pregnancy [18,19].
We therefore aimed to prospectively study longitudinal hemody-
namic adaptation to pregnancy in women with structural heart disease
and asses the inﬂuence of this cardiac adaptation on postpartum cardiac
function.
2. Methods
The prospective single center observational study was conducted from 2007 until
2010 in a joint collaboration by the departments of Cardiology and Obstetrics at the
Erasmus MC. Women with inherited or acquired structural heart disease visiting the
826 J. Cornette et al. / International Journal of Cardiology 168 (2013) 825–831outpatient clinic of cardiology and/or obstetrics for preconceptional counseling or
pregnancy during the study period were invited to participate. Women received an
individualized, standard management by a multidisciplinary team consisting of ded-
icated cardiologists, obstetricians and anesthesiologists according to international
guidelines.
Maternal and uteroplacental hemodynamics were assessed by transthoracic echocar-
diography and obstetric Dopplers. Maternal and pregnancy outcomes were assessed. Car-
diac measurements were performed before pregnancy, in each trimester of pregnancy
and sixmonths postpartum. Obstetric Dopplermeasurements of the uterine and umbilical
artery were performed in the second and third trimesters. Preconceptional hemodynam-
ics were investigated at inclusion or retrieved from a recent previous echocardiographic
exam. Pre and post pregnancy measurements were performed irrespective of the men-
strual cycle, method of anticonception and breast feeding status. The studywas approved
by the medical ethical committee of the ErasmusMCUniversity Medical Centre of Rotter-
dam and all participants gave written informed consent. The authors of this manuscript
have certiﬁed that they complywith the Principles of Ethical Publishing in the Internation-
al Journal of Cardiology.
2.1. General outcomes
Demographics, cardiac diagnoses, obstetric outcomes and both maternal and ob-
stetric complications were prospectively recorded. Post-partum hemorrhage (PPH)
was deﬁned as blood loss above 500 ml after vaginal delivery and 1000 ml after cesar-
ean section [20].
Birthweight centiles, corrected for gestational age, maternal race, parity and fetal
sex were derived from the Dutch national reference curves [21]. A birthweight less
than the 10th percentile, was considered as small for gestational age (SGA).
Hypertension (HT) during pregnancy was classiﬁed as either pre-existent (occur-
ring before 20 weeks of gestation), gestational hypertension (de novo hypertension
without proteinuria occurring after 20 weeks of gestation) or pre-eclampsia (hyper-
tension in combination with proteinuria) [22].Fig. 1. Organogram of the study population with details on cardiac diagnosis. * Five women w
and one woman with a dilated cardiomyopathy.Preterm delivery was deﬁned as a delivery occurring before 37 weeks of gestation.
Pregnancy loss was deﬁned as a miscarriage before and intrauterine death from
20 weeks of gestation.
2.1.1. Echography
Transthoracic echocardiographywas performedusing commercially available devices
with sector transducers (SONOS 7500, Philips Medical Systems, Best, The Netherlands or
iE33, Philips Medical Systems, Best, The Netherlands), according to the guidelines of the
American Society of Echocardiography and, when necessary, adapted to the structural ab-
normality [23].
Diastolic and systolic volumes were computed from the left ventricular end systol-
ic and end diastolic diameters (LVESD, LVEDD) using the Teicholz formula and frac-
tional shortening (FS) and ejection fraction (EF) were calculated accordingly [24].
Left ventricular mass (LVmass) was calculated using the Devereux formula [25]. Left
ventricular outﬂow tract diameter was obtained from the parasternal long access
view and left ventricular outﬂow tract velocity time integral from the apical ﬁve cham-
ber view. Stroke volume (SV) was calculated by multiplying left ventricular outﬂow
area with left ventricular velocity time integral, cardiac output (CO) by multiplying
stroke volume with heart rate. Diastolic function was assessed by pulsed wave Doppler
of the mitral inﬂow (E/A ratio) and tissue Doppler of the septal mitral annulus (E/E′
ratio).
Obstetric Dopplers were obtained with commercially available ultrasound devices
with curved array transducers (iU22, Philips Ultrasound Bothell, WA, USA and Voluson
730 Expert G.E, Medical systems, Zimpf, Austria).
Pulsatility index of the umbilical artery (Umb PI) and mean pulsatility index of
both uterine arteries (Uter PI) were obtained by color directed pulsed wave Doppler.
2.2. Statistical analysis
Continuous variables are displayed as means with a standard deviation (SD) and
range, discrete variables are displayed as counts and proportions.ith mechanical aortic and/or mitral valve. ** One woman after previous chemotherapy
Table 1
Detailed information on type of structural heart disease, previous interventions, preconceptional cardiac condition and WHO group of the study population. Abbreviations in order
of appearance: WHO: WHO group, RHD: rheumatic heart disease, AVR: aortic valve replacement, MVR: mitral valve replacement, //: subsequent intervention, TV: tricuspid valve,
AF: atrial ﬁbrillation, AS: aortic valve stenosis, bicus AV: bicuspid aortic valve, MS: mitral valve stenosis, LV: left ventricle, MV: mitral valve, ACS: acute coronary syndrome, Ao asc:
aorta ascendens, PS: pulmonary valve stenosis, MI: mitral valve insufﬁciency, LA: left atrium, DM: diabetes mellitus, RF: renal failure, Coarct: aortic coarctation, HT: hypertension,
APVD: anomalous pulmonary venous drainage, ASD I: atrium septum defect type 1, Le–Ri shunt: left to right shunt, RV: right ventricle, TI: tricuspid valve insufﬁciency, VSD: ven-
tricular septum defect, PODB: persistent open ductus of Botalli, PA: pulmonary artery, PV: pulmonary valve, TOF: tetralogy of Fallot, RA: right atrium, RV: right ventricle, PI: pul-
monary valve insufﬁciency, AI: aortic valve insufﬁciency, ASD II: atrium septum defect type 2, DCM: dilated cardiomyopathy, CM: cardiomyopathy, TGA: transposition of the
great arteries: pAVSD: partial atrioventricular septum defect, AMI: acute myocardial infarction, PTCA: percutaneous transluminal coronary angioplasty, RCA: right coronary artery,
LAD: left anterior descendens coronary artery, RCX: ramus circumﬂexus.
Diagnosis Interventions prior to
pregnancy
Condition prior to
pregnancy
WHO
RHD St Judes AVR (2×), St Judes MVR//TV plasty (2×) AF 3
RHD St Judes MVR//St Judes AVR AF 3
AS (bicus AV) St Judes AVR Aortic root dilatation 48 mm 3
MS (congenital) St-Judes MVR Good LV and MV function after previous valve thrombo-
sis with ACS
3
AS (bicus AV) Homograft Ao asc 43 mm 2
PS balloon dilatation Mild PS 1
MI No Severe MI, dilated LA with DM and RF 1
Coarct, bicus AV Patch//valvulotomy//Ross//stent recoarctation//Bentall No rest coarct, no HT 3
Coarct, bicus AV End to end anastomosis Mild AS, no rest coarct, Ao asc 40 mm, no HT 2
Coarct, APVD Subclavian ﬂap Mild rest coarct, no HT 2
Coarct, ASD I End to end anastomosis//balloon dilatation Mild rest coarct, HT, Le-Ri shunt over ASD and elevated
RV ﬁlling pressures
3
Coarct, bicus AV, cervi-
cal arch
End to end anastomosis Mild rest coarct, no HT, Ao asc 44 mm 3
Coarct End to end anastomosis No rest coarct, no HT, moderate MI and TI 2
Coarct End to end anastomosis Mild rest coarct, HT 2
Coarct, bicus AV End to end anastomosis//balloon dilatation Mild rest coarct, HT, Ao asc 37 mm 2
Coarct, VSD,
PODB
Subclavian ﬂap, PA banding, closure PODB//PA debanding, PV plasty (2×), balloon
dilatation recoarctation
Mild rest coarct, mild PS, no HT 2
VSD, subvalvular
aortic membrane
Closure VSD (2×), resection subvalvular aortic membrane Ao asc 41 mm 2
TOF Closure VSD, transannular patch Dilated RA and RV, mild PS and severe PI 3
TOF, atresia left
PA
Closure VSD and PODB, transannular patch Mild PS 2
TOF Closure VSD, transannular patch//homograft for severe PI Moderate PI 2
TOF, atresia PA Waterston//Rastelli//plasty for PS, closure VSD Severe AI and moderate PI 3
TOF Closure VSD, transannular patch//homograft Mild PI 2
TOF Blalock-Taussig//closure VSD, infundibulectomy 2×//balloon dilatation PV Moderate PI 2
VSD No Mild Le-Ri shunt 2
VSD, ASD II No Mild Le-Ri shunt 2
VSD, double
oriﬁce MV
PA banding//PA debanding, closure VSD//MV plasty Mild MI and PS 2
DCM (familial) No Mild LV impairment 2
CM (chemotherapy) No Dilated LV, mild LV impairment, mild MI 2
TGA Senning Mild RV impairment 3
TGA Mustard Mild RV impairment 3
pAVSD Closure ASD, VSD, MV plasty Moderate MI 2
pAVSD Closure ASD (2×), VSD (2×), MV plasty (2×) and TV plasty Moderate MI, dilated LA 2
AMI (inferioposterior) PTCA RCA, stent LAD and RCX//PTCA LAD for restenosis Mild LV impairment 3
Marfan syndrome No Aorta 39 mm 2
Ebstein anomaly RV and TV plasty (Chauvaud), partial cavopulmonary shunt AF, severe TI, RV impairment 3
827J. Cornette et al. / International Journal of Cardiology 168 (2013) 825–831To investigate the longitudinal evolution over time of the individual cardiac and
obstetric Doppler parameters and to account for the correlation in the measurements
taken from the same patients, a repeated measurement analysis using linear mixed ef-
fect models was performed [26]. As the evolution of each parameter during pregnancy
may not be linear, we used in our model speciﬁcation second degree polynomials for
both the ﬁxed and random effects parts. The models' assumptions were validated
using residual plots. The analysis was performed in the R statistical software (version
2.14.0, 2011-10-31) using package nlme (version 3.1-102). The signiﬁcance level was
set at 5% and no multiple testing corrections were applied.
Differences between pre-and post-pregnancy values were analyzed with an F-test.
To assess whether the evolution during pregnancy predicted this pre–post pregnancy
difference, the area under the longitudinal trajectory during pregnancy using linear
mixed effect models was computed and subsequently the association between this
area and pre–post pregnancy difference was tested.
To investigate the association between fetal growth and cardiac adaptation, these
areas were also correlated with adjusted birthweight centiles and evolution in uterine
artery ﬂow.
To assess the inﬂuence of the severity of cardiac condition and the occurrence of
pregnancy complications on the longitudinal evolution of the parameters, the popula-
tion was divided in two groups. For the severity of cardiac condition, the division was
based on the WHO cardiac function classiﬁcation (WHO classes 1–2 versus WHO clas-
ses 3–4) [27]. For the occurrence of pregnancy complications, only those associated
with maladaptation to hemodynamic changes were taken into account. As such thepopulation was divided based on the occurrence of hypertension and/or small for ges-
tational age fetuses (HT/SGA).
The same types of analysis as for the whole population were performed, allowing
for differences in the average longitudinal evolutions per risk group. Likelihood ratio
tests for differences in average longitudinal evolutions between both groups were cal-
culated as well as differences between the pre–post pregnancy values. The effect of the
severity of cardiac condition on adjusted birthweight centiles and occurrence of com-
plications was analyzed with a Wilcoxon test and Fisher's exact test respectively.3. Results
Thirty-ﬁve women with structural heart disease were invited to par-
ticipate into the study. Thirty-two of them became pregnant and 29
reached a gestational age beyond the limits of viability (24 weeks). One
woman had a spontaneous ﬁrst trimester miscarriage, one woman
miscarried after a septic episode following a ﬁrst trimester reduction of
a spontaneous triplet to a singleton pregnancy and onewomanhad an in-
trauterine death with signs of severe placental insufﬁciency at 20 weeks
gestation.
Table 2
Details of maternal and obstetric complications and outcomes.
Complications N % WHO 1–2 (n) WHO 3–4 (n) Remarks
Cardiac 21 11
Valve thrombosis 1 3% – 1 Aortic valve thrombosis leading to heart
failure
Heart failure 1 3% – 1
Non-cardiac
Kidney transplant 1 3% 1 – Kidney failure during pregnancy in diabetic
women with pre-existent kidney dysfunc-
tion necessitating postpartum dialysis and
transplant
Sepsis 1 3% 1 After early reduction of a triplet pregnancy
Suicide attempt 1 3% – 1
Post partum
depression
2 6% 1 1
Pyelonefritis 1 3% 1
Obstetric
Pre-existent hypertension 3 9% 2 1
Gestational hypertension 3 9% 3 –
Pre-eclampsia 1 3% 1 –
Preterm delivery 3 9% 1 2 343/7, 351/7, 356/7 weeks
Postpartum hemorrhage 8 25% 5 3
Cesarean section 7 22% 6 1
early miscarriage 2 6% 1 1
Fetal-neonatal
Intrauterine death 1 3% – 1 At 21 weeks
Major congenital
abnormality
1 3% 1 – Trisomy 21 with duodenal atresia
NICU admission 3 9% 1 2
SGA 6 18% 2 4
Pregnancy outcomes Mean SD WHO 1–2 (mean) WHO 3–4 (mean) Median Min Max
Gestational age
(weeks)
39 2 39.175 38.011 39 343/7 416/7
Birthweight (g) 3156 587 3319 2792 3255 1810 4100
Apgar 5 minute 9 1 9.40 9.56 10 8⁎ 10
* Excluding the intrauterine death at 21 weeks.
828 J. Cornette et al. / International Journal of Cardiology 168 (2013) 825–831Fig. 1 represents an organogram of the study population. Table 1 of-
fers details on diagnosis, previous cardiac interventions, the cardiac
condition before pregnancy aswell as theWHO risk group classiﬁcation
for eachwomen individually. Of the 32 includedwomen, 85% had a con-
genital structural heart defect and 82% had a prior cardiac intervention.
Fifty-six percent of women were nulliparous at inclusion. Mean age at
delivery was 32 years (SD: 4.3 years, Range: 24 to 41 years) and mean
BMI was 25 (SD: 3.9, Range: 18 to 34).
Majormaternal (both cardiac and non-cardiac) and/or obstetric (mis-
carriage, fetal death, gestational hypertension, pre-eclampsia, SGA, PPH
and major congenital abnormality) complications occurred in 62.5% of
pregnancies. There was no signiﬁcant difference in complication rate be-
tween the low risk (WHO 1–2) and high risk (WHO 3–4) groups.
Threewomen had pre-existent atrial ﬁbrillation and 3 otherwomen
reported transient episodes of palpitations. Therewere nonew arrhyth-
mic complications during the study period. One woman developed a
thrombosis of her prosthetic aortic valve (St-Judes) at 32 weeks, lead-
ing to heart failure and requiring postpartum valve replacement.
Details of maternal and obstetric complications as well as obstetric
outcomes are represented in Table 2.
The longitudinal proﬁles over time of the echocardiographic and
uteroplacental parameters, starting before pregnancy until six months
postpartum, are presented in Fig. 2 and estimated regression coefﬁ-
cients in Table 3.
A statistically signiﬁcant linear evolution was observed towards a
larger LVESD (P=0.001) and smaller FS (P=0.001) and EF (P≤0.001).
E/E′ ratio (P=0.008), SV (P=0.045), CO (P=0.028), LVmass (P=
0.005) as well as uterine and umbilical artery PI (P≤0.001, P≤0.001 re-
spectively) showeda statistically signiﬁcant parabolic evolution (quadrat-
ic effect) with increase during pregnancy for the cardiac parameters and
decrease for the obstetric Doppler indices.There was a statistically signiﬁcant increase in LVESD (P=0.001)
and E/E′ ratio (P=0.006) and decrease in FS (P=0.001) and EF
(P=0.001) after pregnancy as compared to before pregnancy, how-
ever evolution during pregnancy was not predictive for this differ-
ence. Neither was it related to evolution in uterine artery ﬂow nor
with adjusted birthweight.
The inﬂuence of severity of cardiac structural defect based on
WHO class on longitudinal evolution of the parameters is illustrated
in Fig. 3. There were no signiﬁcant differences in average evolution
over time between groups except for heart rate (LRT 9.78, P=0.021).
Severity of structural heart defects only inﬂuenced heart rate on pre–
post pregnancy difference. Adjusted birthweight centiles were sig-
niﬁcantly higher in the low risk group (WHO1–2) (median=38:
IQR 35.6) as compared to the high risk group (WHO3–4) (median=
14: IQR 24) (P=0.04).
Thirteenwomen presentedwith pregnancy complications associated
with hemodynamic maladaptation (HT/SGA). There were no signiﬁcant
differences in average longitudinal evolution of the parameters between
patients with and without HT/SGA. The corresponding ﬁtted average
longitudinal evolutions are illustrated in Fig. 4. There was a signiﬁcant
pre–post pregnancy difference for the LVEDD (mean diff=−2.97 mm,
P=0.031) between patients with and without HT/SGA.
4. Discussion
Our results offer an insight on both hemodynamic adaptation to
pregnancy and long term inﬂuence of pregnancy on cardiac function
in a population of women with structural heart disease. They show
an attenuated cardiovascular adaptation with reduction in systolic
function and progression of diastolic dysfunction during pregnancy,
which persist 6 months after pregnancy.
Fig. 2. Fitted longitudinal proﬁles of each parameters for the whole population. The dashed lines denote 95% point-wise conﬁdence intervals. The symbol ‘&’ denotes parameters for
which there was a signiﬁcant time effect, and the symbol ‘*’ parameters for which there was a signiﬁcant difference between pre- and post pregnancy measurements.
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with steep rise in the ﬁrst half and a more gradual plateau-like phase
in the second half of pregnancy.
However, the magnitude of increase seems lower than in previ-
ously described normal pregnant populations and more comparableTable 3
Estimated regression coefﬁcients per parameter for the whole population.
Parameter Coef Value Std. error t-Value P-Value
HR Intercept 75.78 1.39 54.48 b0.001
Time 0.01 0.02 0.76 0.447
Time2 −0.00 0.00 −2.02 0.046
LVEDD Intercept 49.11 0.82 59.93 b0.001
Time 0.01 0.01 0.91 O.366
Time2 −0.00 0.00 −0.43 0.667
LVESD Intercept 32.63 0.88 37.02 b0.001
Time 0.02 0.01 2.50 0.014
Time2 0.00 0.00 0.08 0.939
E/A Intercept 1.69 0.10 16.98 b0.001
Time 0.00 0.00 0.06 0.954
Time2 −0.00 0.00 −1.22 0.225
E/E′ Intercept 10.52 0.60 17.63 b0.001
Time 0.02 0.01 3.10 0.003
Time2 −0.00 0.00 −2.96 0.004
FS Intercept 33.84 1.23 27.56 b0.001
Time −0.04 0.02 −2.15 0.034
Time2 −0.00 0.00 −0.76 0.452
EF Intercept 56.61 1.71 33.08 b0.001
Time −0.05 0.02 −2.22 0.029
Time2 −0.00 0.00 −0.74 0.460
SV Intercept 75.03 3.68 20.38 b0.001
Time 0.08 0.05 1.75 0.084
Time2 −0.00 0.00 −2.55 0.013
CO Intercept 5.67 0.30 18.95 b0.001
Time 0.01 0.00 2.17 0.034
Time2 −0.00 0.00 −2.73 0.008
LVmass Intercept 155.01 6.55 23.65 b0.001
Time 0.14 0.08 1.84 0.069
Time2 −0.00 0.00 −3.25 0.002
UterPI Intercept 3.81 0.45 8.48 b0.001
Time −0.21 0.04 −4.83 b0.001
Time2 0.00 0.00 3.69 0.001
UAPI Intercept 1.84 0.13 14.71 b0.001
Time −0.03 0.00 −5.68 b0.001to the pattern observed in pregnancies complicated by growth re-
striction and pregnancies at high altitude [10,11,13–15,28].
The pre-pregnancy LVmass was already elevated in our population,
comparable to third trimester levels for normal healthy women [17].
While somewhat attenuated, we still observed a statistically signiﬁcant
increase in LVmass during pregnancy.
Our data also showed a gradual decline in FS and EF due to an in-
crease in LVESD, similar to normal pregnancy [17]. While the absolute
values persisted within normal ranges, the decline continued until six
months postpartum leading to a statistically signiﬁcant difference be-
tween pre- and post-pregnancy measurements.
These ﬁndings suggest a negative inﬂuence of pregnancy on sys-
tolic function in women with structural cardiac disease. Our data
are in contrast to Uebing's ﬁndings who could not observe a deleteri-
ous effect pregnancy on left ventricular function [19]. One could ques-
tion the accuracy of EF and FS derived from the Teicholz formula in
reﬂecting systolic function in pregnant women with structural heart
disease. As most other echocardiographic volume estimations equally
have intrinsic limitations, we believe that MRI analysis of systolic
function is necessary to conﬁrm our ﬁndings.
Normally the E/A ratio decreases with gestational age, as the im-
portance of atrial contribution to ventricular ﬁlling increases along
with HR towards the end of pregnancy [13,17,29]. We observed a rel-
atively constant E/A ratio and HR within normal ranges throughout
pregnancy in our population.
However, E/E′ ratio,whichwas already elevated before pregnancy in
our population, showed a further signiﬁcant increase with gestational
age. While the pattern is similar to normal pregnancy the absolute
valueswere far above bothnormal and pre-eclamptic pregnancy values,
clearly in the pathological range [11–13].
Our ﬁndings suggest a progressive diastolic dysfunction in women
with structural heart disease with advancing gestational age. In normal
pregnancy, increased load is compensated by myocardial hypertrophy.
Due to elevated baseline levels, the capacity for further expansion in
LVmass seems reduced in our population. Increments in load therefore
lead to elevation of ﬁlling pressures, as reﬂected by the E/E′ ratio.
The signiﬁcant difference in pre–post-pregnancy E/E′ ratio, indi-
cates a persistent negative inﬂuence of pregnancy on diastolic func-
tion in women with structural heart disease 6 months postpartum.
Fig. 3. Fitted longitudinal proﬁles for each parameter divided according to the severity of the cardiac condition. The dark gray area surrounding the dashed red line and lighter gray
area surrounding the full blue line denote the 95% pointwise conﬁdence intervals for the WHO1–2 group and WHO3–4 group respectively. The symbol ‘&’ denotes parameters for
which there was a signiﬁcant difference in the average evolutions in time, and the symbol ‘*’ parameters for which there was a signiﬁcant difference between pre and post preg-
nancy measurements between groups.
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evaluate the transient or permanent nature of these changes.
To our knowledge this is the ﬁrst study assessing diastolic function
during and after pregnancy in women with structural heart disease.
Our observations also highlight the importance of tissue Doppler
in the longitudinal assessment of diastolic dysfunction during preg-
nancy. As important volume- and loading shifts occur along with ges-
tational age, changes are best evaluated by a combined assessment ofFig. 4. Fitted longitudinal proﬁles for each parameter divided according to the occurrence of
dashed red line and lighter gray area surrounding the full blue line denote the 95% pointwi
small for gestational age fetus respectively. The symbol ‘*’ parameters for which there wasthe pulsed wave mitral inﬂow Doppler and load independent tissue
Doppler of the mitral annulus.
Not surprisingly, all these ﬁndings suggest a mildly reduced car-
diac potential for adaptation to the normal requisites of pregnancy
in women with structural heart disease. The maladaptation is partly
comparable to that observed in women with growth restriction and
gestational hypertension, however diastolic dysfunction is more se-
vere [11,30].hypertension and/or small for gestational age fetus. The dark gray area surrounding the
se conﬁdence intervals for the group with and the group without hypertension and/or
a signiﬁcant difference between pre and post pregnancy measurements.
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diac adaptation we observed a similar pattern betweenWHO1–2 and
WHO3–4 groups. While the trend seems visually more pronounced
for the severe group (WHO 3–4) in Fig. 3, it failed to show statistical
signiﬁcance except for heart rate. Considering the known association
between fetal growth restriction and hemodynamic maladaptation,
the difference in adjusted birthweight centiles nevertheless empha-
sizes the impression of a reduced cardiac adaptive potential in high
risk groups (Fig. 3) and thus requires further investigation in a larger
population.
A similar effect is observed for the inﬂuence of HT/SGA in Fig. 4.
This suggests that the reduced cardiac reserve is probably intrinsic
to the structural heart disease rather than caused by the relatively
high prevalence of hypertensive complications and SGA in our popu-
lation (40%).
While the incidence of cardiac complications was relatively low
in our population, the overall complication rate was high (62.5%).
Previous research has demonstrated that women with heart disease
are also at increased risk for non-cardiac and obstetric pathology
[4–6]. Most hypertensive complications occurred in women with
known risk factors such as aortic stenosis and coarctation [4]. As
expected, SGA infants occurred mostly in women with atrial repair
of transposition of the great arteries and pulmonary stenosis spectra
[31,32]. Of note is the occurrence of post-partum depression in 2
women and a suicide attempt during pregnancy in a third woman.
One could imagine that the burden of cardiac disease adds to the nor-
mal psychological challenge which accompanies pregnancy and
early motherhood.
A higher incidence of depression or psychiatric disturbances has
not been described in women with structural heart disease. It merits
attention in further prospective trials as both cardiac disease and sui-
cide are the main causes of maternal mortality in the western world
[33].
Data on hemodynamic adaptation in pregnancy in women with
structural heart disease are scarce and have not been described in a
longitudinal matter. Therefore comparison with other studies is very
difﬁcult. Lesniak et al. analyzed the evolution of echocardiographic
parameters of various valvular conditions during pregnancy, describ-
ing slightly different patterns according to the speciﬁc valvular pa-
thology [9].
The strength of our study lies in its prospective nature and longi-
tudinal assessment of hemodynamic adaptation during pregnancy
as well as in the observation of the inﬂuence of pregnancy on long
term cardiac outcome.
The main weaknesses of our study are the relatively limited number
of patients, the heterogeneity of structural heart diseases and the absence
of a control group. Future prospective research should be multicentric in
order to allow pathology speciﬁc pattern analysis. Where evolutions dur-
ing pregnancy were compared with previously published populations of
pregnantwomen, amatched control groupwould certainly be preferable,
ideally with inclusion of preconceptional measurements.
In conclusion our results show an attenuated cardiovascular adap-
tation to pregnancy in women with structural heart disease. Our data
indicate a reduction in systolic function and progression diastolic dys-
function during pregnancy, which persist 6 months after pregnancy.References
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